[1]
Daria Sztefka et al. 2026. CARDIOMETABOLIC STRATEGIES IN HEART FAILURE AND CHRONIC KIDNEY DISEASE: FROM GLP-1 RECEPTOR AGONISTS TO IMPROVED QUALITY OF LIFE AND TECHNOLOGY-ENABLED CARE. International Journal of Innovative Technologies in Social Science. 3, 1(49) (Mar. 2026). DOI:https://doi.org/10.31435/ijitss.1(49).2026.5402.